Corporate News Report – Agape ATP Corporation
The share of Agape ATP Corporation (ticker ATPC) slipped by 0.64 % within the 24‑hour window that closed at 10:37 AM Central Europe on Wednesday, 21 October 2026. The current market price stands at USD 1.54 on the Nasdaq exchange. With an outstanding supply of 1 000 000 shares, the company’s market capitalisation is approximately USD 1.6 million. In the last 24 hours, roughly USD 28.1 thousand of Agape ATP stock was traded.
Trading Performance
- Year‑to‑date: The stock has declined 31.88 % since the close of last month.
- Moving averages: The simple moving average over the previous 200 days is USD 2.78.
- Historical peaks: The 52‑week high was USD 73.50 on 12 September 2025, while the 52‑week low reached USD 1.50 on 19 October 2026.
Contextual Market Activity
During the same 24‑hour period, several peer companies exhibited varied performance:
| Stock | Price (USD/GBX) | % Change | Market Capitalisation | Notable Developments |
|---|---|---|---|---|
| Genprex (GNPX) | 2.13 | –2.37 % | 1.7 m | – |
| Change Agents (CHGA) | 1.40 | –14.65 % | 1.8 m | Filed a report on 19 Oct 2026 detailing financing activity, including waiver agreements with Dune Equity Holdings and FirstFire Global Opportunities Fund, issuance of pre‑funded warrants, unsecured promissory notes, and a brief loan advance from the chief strategy officer. |
| Tenon Medical (TNON) | 2.51 | –9.26 % | 1.8 m | – |
| Aoti (AOTI.L) | 135 GBX | 0 % | 184.4 m | – |
| Kairos Pharma (KAPA) | 0.58 | –5.16 % | 1.8 m | – |
Company Profile
Agape ATP Corporation, headquartered in Kuala Lumpur, Malaysia, focuses on the discovery and development of nutritional supplements aimed at preventing conditions such as ulcers, tumors, cancer formation, and cardiovascular disease. The company’s product portfolio is marketed exclusively within Malaysia. Agape ATP’s corporate website is www.agapeatp.com , and its shares are listed on the Nasdaq stock exchange.
